Using the ROX Index to Predict Treatment Outcome for High-Flow Nasal Cannula and/or Noninvasive Ventilation in Patients With COPD Exacerbations

CONCLUSIONS: The ROX index applied to adults with COPD exacerbations treated with HFNC and/or NIV required higher scores to achieve similar prediction of low risk of treatment failure when compared to subjects with hypoxemic respiratory failure/pneumonia. ROX scores < 4.88 did not accurately predict intubation or death.PMID:38653556 | DOI:10.4187/respcare.11544

Source: Respiratory Care - April 23, 2024 Category: Respiratory Medicine Authors: Brett Z Schaeffer Sarina A Fazio Jacqueline C Stocking Jason Y Adams Anna Liu Hugh B Black Richart W Harper Irene Cortes-Puch Timothy E Albertson Brooks T Kuhn Source Type: research